PTEN loss occurs in approximately 20% of human gastric cancers and is associated with phosphoinositide 3-kinase/protein kinase B pathway activation and poor prognosis (Tamura, 2006; Tran et al., 2013; Zhao et al., 2019; Chiappini et al., 2017). The gene discussed is PTEN; the disease is gastric cancer.